Loading clinical trials...

In Vivo Alzheimer Proteomics | Clinical Trials | Clareo Health

TERMINATEDNANCT02263235

In Vivo Alzheimer Proteomics

In France, an estimated 860 000 patients are affected by Alzheimer Disease (AD) which represents, as in other developed countries, a major public health issue. In many cases, AD diagnosis is uncertain...

Lead sponsor: University Hospital, Montpellier•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Study of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PD

NCT07187843 · Parkinson Disease, Parkinsonian Disorders, and more

RECRUITINGNA

Retinal Hyperspectral Imaging in Neurodegenerative Diseases

NCT07545473 · Dementia, Neurodegenerative Diseases, and more

RECRUITINGPhase 1

A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease

NCT07543861 · Parkinson Disease

RECRUITING

Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms

NCT05748028 · Parkinson Disease, Multiple System Atrophy

RECRUITINGNA

Effect of Motor Imagery Added to Rehabilitation on Balance and Kinesiophobia in Patients With Parkinson's Disease

NCT07495462 · Parkinson Disease (PD)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 28, 2021Terms

Trial snapshot

StatusTERMINATED

PhaseNA

Enrollment89

Start dateOct 2013

Last updatedDec 28, 2021

Condition

Probable Alzheimer Disease Parkinson Disease Neurological Disease Without Cognitive Degradation Brain Trauma Acute Hydrocephaly

Locations shown

Laboratoire de Biochimie et Protéomique Clinique, CHU Montpellier

Montpellier

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 28, 2021Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions